<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02176603</url>
  </required_header>
  <id_info>
    <org_study_id>PKU-EnDys</org_study_id>
    <nct_id>NCT02176603</nct_id>
  </id_info>
  <brief_title>Observational Study of Endothelial Dysfunction in Phenylketonuria</brief_title>
  <official_title>Observational, Investigator Initiated, Monocentric Study of the Endothelial Dysfunction in Adolescent and Adult Patients With Phenylketonuria Due to Phenylalanine Hydroxylase Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johannes Gutenberg University Mainz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether adolescent and adult patients with
      phenylketonuria who are on long-term phenylalanine-restricted diet suffer from endothelial
      dysfunction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is the examination of endothelial dysfunction and oxidative stress
      markers in adolescent and adult patients with phenylketonuria (PKU), in correlation to
      phenylalanine values und phenylalanine-restricted diet. 25-50 patients with PKU aged ≥16
      years of age and a control group of 25 age- and sex-matched healthy volunteers will be
      included in the study.

      Endothelial dysfunction will be measured by venous occlusion plethysmography on the lower
      legs in the PKU patients and in the control group. Wave velocity, aortic stiffness, and
      intima media thickness of the common carotid artery will be measured by vicorder and duplex
      ultrasound scanner in the PKU patients and in the control group. Analyses of phenylalanine
      metabolites and renal function will be performed only in the PKU patients, analyses of
      oxidative stress markers in the PKU patients and in the control group. Dietary protocols of
      the patients with PKU will be calculated for their daily phenylalanine, total protein, and
      calorie intake. Results of the study will be kept in the medical records and paper case
      report forms. Data will be analyzed only in pseudonymized form.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">January 1, 2017</completion_date>
  <primary_completion_date type="Actual">July 22, 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Post-ischaemic venous flow (measured in ml/min) in patients with PKU compared to healthy volunteers</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aortic pulse wave velocity in patients with PKU compared to healthy volunteers. Intima media thickness in patients with PKU compared to healthy volunteers.</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">51</enrollment>
  <condition>Phenylketonuria</condition>
  <condition>Endothelial Dysfunction</condition>
  <arm_group>
    <arm_group_label>Patients with Phenylketonuria</arm_group_label>
    <description>Patients with Phenylketonuria due to phenylalanine hydroxylase deficiency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Control group of healthy volunteers</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma, serum, urine will be retained. All blood samples will be destroyed immediately after
      having analyzed the above mentioned parameters.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients aged ≥ 16 years with PKU diagnosed by newborn screening who are followed up in the
        Metabolic Unit of the Charité University Medical Center Berlin (Interdisciplinary Center
        for Metabolic Diseases, Dept. of Hepatology and Gastroenterology, as well as Dept. of
        Pediatric Endocrinology, Gastroenterology and Metabolic Diseases).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  phenylketonuria due to phenylalanine hydroxylase deficiency

          -  age ≥16 years

        Exclusion Criteria:

          -  age &lt;16 years

          -  pregnancy or maternity

          -  late-treated phenylketonuria

          -  phenylketonuria due a defect in BH4 synthesis or BH4 regeneration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julia B Hennermann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johannes Gutenberg University Mainz, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Uwe Querfeld, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University, Berlin, Germany</affiliation>
  </overall_official>
  <reference>
    <citation>Briese S, Claus M, Querfeld U. Arterial stiffness in children after renal transplantation. Pediatr Nephrol. 2008 Dec;23(12):2241-5. doi: 10.1007/s00467-008-0894-y. Epub 2008 Jun 27.</citation>
    <PMID>18584211</PMID>
  </reference>
  <reference>
    <citation>Ribas GS, Sitta A, Wajner M, Vargas CR. Oxidative stress in phenylketonuria: what is the evidence? Cell Mol Neurobiol. 2011 Jul;31(5):653-62. doi: 10.1007/s10571-011-9693-2. Epub 2011 Apr 23. Review.</citation>
    <PMID>21516352</PMID>
  </reference>
  <reference>
    <citation>Kracht D, Shroff R, Baig S, Doyon A, Jacobi C, Zeller R, Querfeld U, Schaefer F, Wühl E, Schmidt BM, Melk A; 4C Study Consortium. Validating a new oscillometric device for aortic pulse wave velocity measurements in children and adolescents. Am J Hypertens. 2011 Dec;24(12):1294-9. doi: 10.1038/ajh.2011.147. Epub 2011 Aug 25.</citation>
    <PMID>21866186</PMID>
  </reference>
  <reference>
    <citation>Hennermann JB, Roloff S, Gellermann J, Vollmer I, Windt E, Vetter B, Plöckinger U, Mönch E, Querfeld U. Chronic kidney disease in adolescent and adult patients with phenylketonuria. J Inherit Metab Dis. 2013 Sep;36(5):747-56. doi: 10.1007/s10545-012-9548-0. Epub 2012 Nov 9.</citation>
    <PMID>23138985</PMID>
  </reference>
  <reference>
    <citation>Hennermann JB, Querfeld U. Unknown pathomechanisms of renal impairment in PKU. J Inherit Metab Dis. 2013 Nov;36(6):1087-8. doi: 10.1007/s10545-013-9652-9. Epub 2013 Sep 17.</citation>
    <PMID>24043382</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2014</study_first_submitted>
  <study_first_submitted_qc>June 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2014</study_first_posted>
  <last_update_submitted>February 22, 2017</last_update_submitted>
  <last_update_submitted_qc>February 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Uwe Querfeld</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>phenylketonuria, endothelial dysfunction, CKD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylketonurias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

